ArticleEuropean journal of nuclear medicine and molecular imaging2026
Diagnostic performance of ¹⁸F-FDG PET/CT radiomics-based machine learning models for pancreatic lesion characterisation: Comparison with visual assessment and evaluation of human-radiomics synergy.
Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe aimed to evaluate the diagnostic performance of ¹⁸F-FDG PET/CT-derived radiomics-based machine learning models for differentiating malignant from benign pancreatic lesions, to compare these models with two sequential stages of visual assessment, and to assess whether incorporation of clinician judgement as a model input provides additional diagnostic gain.
methodsIn this retrospective single-centre study, 853 consecutive patients who underwent ¹⁸F-FDG PET/CT between April 2009 and February 2025 for known or suspected pancreatic lesions were screened, and 466 were included in the final analysis. Final diagnosis was established by histopathology (76.9%) or clinico-radiological follow-up (23.1%). Diagnostic performance was assessed within a five-stage framework consisting of two visual assessment stages and three progressively expanded machine-learning stages. The visual stages comprised first-look assessment based on PET/CT images alone and comprehensive second-look assessment integrating available clinical, laboratory, and multimodal imaging data. The machine-learning stages comprised a hybrid PET + CT radiomics model, an integrated model additionally incorporating clinical, laboratory, semiquantitative PET, and imaging-derived variables, and a human-radiomics synergistic model including the clinician's second-look binary judgement as an input feature. PET-only and CT-only radiomics models were also evaluated as unimodal comparators. Radiomic features were extracted after manual three-dimensional segmentation using 3D Slicer/PyRadiomics, and Random Forest was selected as the final classifier.
resultsOf 466 lesions, 336 (72.1%) were malignant and 130 (27.9%) were benign. First-look visual assessment achieved 93.5% sensitivity, 49.2% specificity, and 81.1% accuracy. Comprehensive second-look assessment improved performance to 97.9% sensitivity, 76.9% specificity, and 92.0% accuracy. Among radiomics-based models, the hybrid PET + CT model outperformed unimodal approaches, achieving 91.1% sensitivity, 66.7% specificity, and 86.8% accuracy. The integrated model did not improve overall accuracy beyond the hybrid model. The human-radiomics synergistic model achieved the highest sensitivity (98.7%) and overall accuracy (93.3%), whereas comprehensive second-look assessment retained slightly higher specificity and NPV.
conclusion¹⁸F-FDG PET/CT radiomics-based machine learning models improved specificity beyond routine first-look visual PET interpretation, approaching the performance of comprehensive second-look visual assessment without requiring additional clinical data. Incorporation of clinician judgement further increased sensitivity, although comprehensive second-look visual assessment by an experienced reader retained the highest specificity and NPV among all approaches. These findings support a complementary, decision-support role for radiomics-based models alongside, rather than in place of, expert visual assessment.
Indexed as
Identifiers
42507007What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.